SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-18-018007
Filing Date
2018-04-10
Accepted
2018-04-10 16:06:53
Documents
4
Effectiveness Date
2018-04-10

Document Format Files

Seq Description Document Type Size
1 DEFA14A bp05609x2_defa14a.htm DEFA14A 25861
2 bp05609x2_img001.gif GRAPHIC 1505
3 bp05609x2_img001.jpg GRAPHIC 2896
4 bp05609x2_img002.gif GRAPHIC 1512
  Complete submission text file 0001140361-18-018007.txt   35438
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37708 | Film No.: 18748080
SIC: 2834 Pharmaceutical Preparations